HUNTERDON CONGRESSMAN Lance Named Congressional Champion of Health Innovation

Congressman Leonard Lance (NJ-07) has been named a Champion of Health Innovation by the Healthcare Leadership Council (HLC).  Members of HLC visited Lance’s Westfield District Office to discuss the state of the country’s health care system and Lance’s work in Congress to spur medical innovation, make health care more affordable and keep care patient-centered.

Health care innovation is one of the most important issues facing the Nation.  I am working in Washington to make health care more affordable for all patients and to keep care focused on their needs.  I am also working to harness the type of innovation that will lead to the next big medical breakthrough,” said Lance, a member of the Energy and Commerce Health Subcommittee. “Our recent successes, from passing the 21st Century Cures Act and new cancer research legislation to postponing the onerous medical device tax and making permanent the critical research and development tax credit, are substantial victories for health care innovation.  I thank the Healthcare Leadership Council for working with me in tackling the many great public health challenges.”

“That Congressman Lance is deserving of this honor is beyond question,” said Mary R. Grealy, president of the Healthcare Leadership Council.  “New Jersey is home to vibrant bioscience and medical technology companies that are transforming American healthcare, and Congressman Lance has led policy efforts that maintain the United States as the global center of medical innovation.  His leadership benefits his state as well as patients and consumers throughout the country.”

The recognition comes as on the heels of a string of successes for Lance’s health care portfolio.  Lance helped pass an extension of the research and development tax credit and a delay in the medical device tax at the end of last year, and Lance’s Breast Cancer Patient Education Act was also recently signed into law, becoming the fourth piece of cancer-fighting legislation in which Lance has been involved to be signed into law, joining the Recalcitrant Cancer Research Act, the FDA Safety Over Sequestration Act and the Gabriella Miller Kids First Research Act.  The landmark 21stCentury Cures Act is also making its way through the U.S. Senate following passage in the House.

Policies that make health care more innovative save lives and boost New Jersey’s vibrant life sciences sector that employs thousands of Garden State residents and delivers billions of dollars to our state economy,” concluded Lance.